Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14360003
[patent_doc_number] => 10301288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/830996
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38548
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 621
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830996
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830996 | Kinase inhibitors | Dec 3, 2017 | Issued |
Array
(
[id] => 12862021
[patent_doc_number] => 20180179181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 15/830769
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830769 | PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE | Dec 3, 2017 | Abandoned |
Array
(
[id] => 17280844
[patent_doc_number] => 11197857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Combination therapy
[patent_app_type] => utility
[patent_app_number] => 16/464439
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 58
[patent_no_of_words] => 35378
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464439 | Combination therapy | Nov 29, 2017 | Issued |
Array
(
[id] => 13748689
[patent_doc_number] => 10167275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => AZD9291 intermediate and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 15/822060
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2371
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15822060
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/822060 | AZD9291 intermediate and preparation method therefor | Nov 23, 2017 | Issued |
Array
(
[id] => 12238460
[patent_doc_number] => 20180071324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'PREPARATION METHOD FOR ANTITUMOR DRUG AP26113'
[patent_app_type] => utility
[patent_app_number] => 15/822092
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2549
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15822092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/822092 | Preparation method for antitumor drug AP26113 | Nov 23, 2017 | Issued |
Array
(
[id] => 17407115
[patent_doc_number] => 11247984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Uracil containing compounds
[patent_app_type] => utility
[patent_app_number] => 16/462178
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55294
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462178 | Uracil containing compounds | Nov 20, 2017 | Issued |
Array
(
[id] => 13289153
[patent_doc_number] => 10155752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Indazoles and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/817550
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22015
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 355
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817550 | Indazoles and use thereof | Nov 19, 2017 | Issued |
Array
(
[id] => 15556705
[patent_doc_number] => 20200062764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => ALKYL PYRROLOPYRIMIDINE ANALOGS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/461300
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461300 | Alkyl pyrrolopyrimidine analogs and methods of making and using same | Nov 16, 2017 | Issued |
Array
(
[id] => 12728560
[patent_doc_number] => 20180134687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => 1-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- I - YL) UREAS AS P38 MAPKINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/812425
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15812425
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/812425 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors | Nov 13, 2017 | Issued |
Array
(
[id] => 16533268
[patent_doc_number] => 10875851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Factor XIIa inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/461849
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15790
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461849 | Factor XIIa inhibitors | Nov 12, 2017 | Issued |
Array
(
[id] => 13209133
[patent_doc_number] => 10118923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Compositions and methods for inhibiting kinases
[patent_app_type] => utility
[patent_app_number] => 15/805693
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12594
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15805693
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/805693 | Compositions and methods for inhibiting kinases | Nov 6, 2017 | Issued |
Array
(
[id] => 15395755
[patent_doc_number] => 10538521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Pyrimidine derivative having antimalarial activity
[patent_app_type] => utility
[patent_app_number] => 16/344471
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24180
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344471 | Pyrimidine derivative having antimalarial activity | Oct 24, 2017 | Issued |
Array
(
[id] => 13051377
[patent_doc_number] => 10047069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Compositions comprising an inhibitor of lysine specific demethylase-1
[patent_app_type] => utility
[patent_app_number] => 15/793512
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10082
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15793512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/793512 | Compositions comprising an inhibitor of lysine specific demethylase-1 | Oct 24, 2017 | Issued |
Array
(
[id] => 12739774
[patent_doc_number] => 20180138425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 15/789096
[patent_app_country] => US
[patent_app_date] => 2017-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15789096
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/789096 | Organic electroluminescent materials and devices | Oct 19, 2017 | Issued |
Array
(
[id] => 13063113
[patent_doc_number] => 10052326
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-08-21
[patent_title] => Antihepatotoxic agents
[patent_app_type] => utility
[patent_app_number] => 15/782462
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 4178
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782462 | Antihepatotoxic agents | Oct 11, 2017 | Issued |
Array
(
[id] => 12177371
[patent_doc_number] => 20180036308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/730559
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23377
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15730559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/730559 | Compounds | Oct 10, 2017 | Issued |
Array
(
[id] => 13763345
[patent_doc_number] => 10174007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/729885
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 3
[patent_no_of_words] => 28861
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729885 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Oct 10, 2017 | Issued |
Array
(
[id] => 17307308
[patent_doc_number] => 11208400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/341410
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 197565
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341410 | Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof | Oct 8, 2017 | Issued |
Array
(
[id] => 15491565
[patent_doc_number] => 20200045971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => PESTICIDAL MIXTURES
[patent_app_type] => utility
[patent_app_number] => 16/340547
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340547 | Pesticidal mixtures | Oct 3, 2017 | Issued |
Array
(
[id] => 15831765
[patent_doc_number] => 20200131164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 16/337298
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337298
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337298 | Dimethylaminoethanol salt of a GLP-1 receptor modulator | Sep 28, 2017 | Issued |